Show simple item record

dc.contributor.authorvan der Velden, Jolanda
dc.contributor.authorGabriele Tocchetti, Carlo
dc.contributor.authorVarricchi, Gilda
dc.contributor.authorBianco, Anna
dc.contributor.authorSequeira, Vasco
dc.contributor.authorHilfiker-Kleiner, Denise
dc.contributor.authorHamdani, Nazha
dc.contributor.authorLeite-Moreira, Adelino
dc.contributor.authorMayr, Manuel
dc.contributor.authorFalcão-Pires, Ines
dc.contributor.authorThum, Thomas
dc.contributor.authorDawson, Dana K
dc.contributor.authorBalligand, Jean-Luc
dc.contributor.authorHeymans, Stephane
dc.date.accessioned2018-06-25T14:46:09Z
dc.date.available2018-06-25T14:46:09Z
dc.date.issued2018-08-01
dc.identifier.citationvan der Velden , J , Gabriele Tocchetti , C , Varricchi , G , Bianco , A , Sequeira , V , Hilfiker-Kleiner , D , Hamdani , N , Leite-Moreira , A , Mayr , M , Falcão-Pires , I , Thum , T , Dawson , D K , Balligand , J-L & Heymans , S 2018 , ' Metabolic changes in hypertrophic cardiomyopathies : Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology ' , Cardiovascular Research , vol. 114 , no. 10 , pp. 1273-1280 . https://doi.org/10.1093/cvr/cvy147en
dc.identifier.issn0008-6363
dc.identifier.otherPURE: 125465877
dc.identifier.otherPURE UUID: 3360b15c-730e-43c5-8629-9c51143e0fd4
dc.identifier.otherPubMed: 29912308
dc.identifier.otherScopus: 85055042436
dc.identifier.urihttp://hdl.handle.net/2164/10659
dc.descriptionJV is supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2014-40 DOSIS. SH has received funding from the European Union Commission’s Seventh Framework programme under grant agreement N° 305507 (HOMAGE), N° 602904 (FIBROTARGETS) and FP7-Health-2013- Innovations-1 N° 602156 (HECATOS). . We acknowledge the support from the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2011-ARENA, CVON2016-Early HFPEF, and ShePREDICTS. This research is cofinanced as a PPP-allowance Research and Innovation by the Ministry of Economic Affairs within Top Sector Life sciences & Health. This research was co-funded by the C3 project “Vision Core Leuven” of the Leuven Universityen
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofCardiovascular Researchen
dc.rightsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comen
dc.subjectJournal Articleen
dc.subjecthypertrophic cardiomyopathyen
dc.subjectmutationsen
dc.subjectmetabolismen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleMetabolic changes in hypertrophic cardiomyopathies : Scientific update from the Working Group of Myocardial Function of the European Society of Cardiologyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/cvr/cvy147


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record